KA2507
CAS: 1636894-46-6
Ref. 3D-LQC89446
| 1mg | A consultar | ||
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Información del producto
KA2507 is a teriparatide analog that acts as an inhibitor of tumor growth. It has been shown to inhibit the growth of cancer cells in both human and Chinese hamster models. KA2507 works by inhibiting trypsin-like proteases, which are involved in the regulation of cell proliferation and apoptosis. This drug has also been shown to have anti-tumor effects when used in combination with methotrexate, a chemotherapy drug commonly used for cancer treatment. Additionally, KA2507 has kinase inhibitory properties and can be detected in urine samples. Studies have also shown that astaxanthin, a natural antioxidant found in seafood, enhances the anti-tumor activity of KA2507.
Propiedades químicas
Consulta técnica sobre: 3D-LQC89446 KA2507
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
